Sage Financial Management Group, Inc. Johnson & Johnson Transaction History

Sage Financial Management Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$155.22 - $162.74 $80,559 - $84,462	519 Added 17.69%	3,453 $546,000
Q4 2023 Jan 17, 2024	BUY	$145.6 - $158.88 $103,084 - $112,487	708 Added 31.81%	2,934 $460,000
Q3 2023 Oct 12, 2023	BUY	$155.75 - $174.48 $346,699 - $388,392	2,226 New	2,226 $347,000
Q1 2022 Apr 28, 2022	BUY	$158.14 - $179.59 $119,711 - $135,949	757 Added 40.31%	2,635 $467,000
Q4 2021 Feb 08, 2022	BUY	$155.93 - $173.01 $292,836 - $324,912	1,878 New	1,878 $321,000
Q3 2021 Oct 26, 2021	SELL	$161.5 - $179.47 $305,396 - $339,377	-1,891 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$153.07 - $170.48 $281,189 - $313,171	1,837 Added 3401.85%	1,891 $311,000
Q4 2020 Feb 08, 2021	SELL	$137.11 - $157.38 $251,871 - $289,107	-1,837 Reduced 97.14%	54 $298,000
Q4 2020 Feb 08, 2021	BUY	$137.11 - $157.38 $259,275 - $297,605	1,891 New	1,891 $298,000

4,161

1.69B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $419B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Sage Financial Management Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Sage Financial Management Group, Inc. with notifications on news.